×

GPhP-ConceptPaper-QAS13-518Rev1_03052013.pdf

Home / Discover /www.who.int/medicines/areas/quality_safety/quality_assurance/

  Parent Folder


GPhP-ConceptPaper-QAS13-518Rev1_03052013.pdf
PDF 4 years ago Get Size
Copy Link   
WHO_SamplingProcedures_GeneralDocument_QAS14_590_10062014.pdf
PDF 4 years ago Get Size
Copy Link   
Samplingprocedure-QAS12-510_31082012.pdf
PDF 4 years ago Get Size
Copy Link   
QAS19_822_Undue_Toxicity.pdf
PDF 4 years ago Get Size
Copy Link   
2016-07-27GPhP-Glossary_QAS16_677.pdf
PDF 4 years ago 637.02 kB
Copy Link   
Local-manufacturing-risk-QAS16-682_24082016.pdf
PDF 4 years ago Get Size
Copy Link   
QAS19_815_Dolutegravir_Lamivudine_Tenefovir_Disoproxil_Tablets.pdf
PDF 4 years ago 692.63 kB
Copy Link   
GoodRegulatory_PracticesPublicConsult.pdf
PDF 4 years ago 1.28 MB
Copy Link   
QAS19_814_Tenofovir_Disoproxil_Fumarate.pdf
PDF 4 years ago 773.54 kB
Copy Link   
QAS17_745_rev1_GMP_sterile_pharmaceutical_products.pdf
PDF 4 years ago Get Size
Copy Link   
28_06_2018_who_certification_scheme_qas18_768_rev1.pdf
PDF 4 years ago 1.01 MB
Copy Link   
Albendazole_Tablets_QAS19_812.pdf
PDF 4 years ago 176.38 kB
Copy Link   
03_07_18_qas_18_777_who_biowaiver_list.pdf
PDF 4 years ago 343.98 kB
Copy Link   
Ciprofloxacin_Tablets_QAS19-810.pdf
PDF 4 years ago 491.90 kB
Copy Link   
QAS18.782_Rev1_IAEA_WHO_gmp_for_radiopharmaceutical_products.pdf
PDF 4 years ago 696.86 kB
Copy Link   
Ciprofloxacin_Hydrochloride_QAS19_809.pdf
PDF 4 years ago 630.24 kB
Copy Link   
QAS19_783_Rev1_WHO_guideline_QMS_requirements_for_NRAs.pdf
PDF 4 years ago 816.24 kB
Copy Link   
Albendazole_Chewable_Tablets_QAS19-800.pdf
PDF 4 years ago 223.59 kB
Copy Link   
2018-07-06_Estradiol_valerate_qas_18_788.pdf
PDF 4 years ago 676.61 kB
Copy Link   
QAS19_786_Rev_1_Water_for_Injection.pdf
PDF 4 years ago 403.98 kB
Copy Link   

Join FilePursuit on FilePursuit Discord Server chat for discussions and more information.